Cancer Genetics

Cancer genetics is the study of how genetic changes contribute to the development and progression of cancer. Genetic changes can occur in two main types of genes: oncogenes and tumor suppressor genes.

Oncogenes are genes that normally help regulate cell growth and division. When mutated or overactive, they can promote uncontrolled cell growth and division, leading to cancer. Tumor suppressor genes, on the other hand, normally help prevent the development of cancer by inhibiting cell growth and division. When these genes are mutated or inactive, cells can grow and divide uncontrollably, leading to the development of cancer.

Genetic testing can help identify mutations in genes that are associated with an increased risk of developing certain types of cancer, such as BRCA1 and BRCA2 mutations in breast and ovarian cancer. Genetic testing can also be used to guide treatment decisions, such as determining whether a patient is likely to respond to certain targeted therapies.

Advances in cancer genetics research have led to the development of new therapies, such as targeted therapies and immunotherapies, that are designed to target specific genetic mutations or changes in cancer cells. Additionally, genetic testing and counseling can help individuals understand their risk of developing cancer and make informed decisions about screening, prevention, and treatment.

    Related Conference of Cancer Genetics

    March 18-19, 2024

    5th Global Summit on Oncology and Hematology

    Zurich, Switzerland
    June 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Barcelona, Spain
    July 11-12, 2024

    24th World Congress on Cancer and Diagnostics

    Vancouver, Canada
    July 18-19, 2024

    14th World Congress on Breast Cancer

    Paris, France
    September 19-20, 2024

    25th World Congress on Cancer Summit

    Paris, France

    Cancer Genetics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in